Head to Head Contrast: AxoGen (AXGN) vs. Viveve Medical (VIVE)

AxoGen (NASDAQ: AXGN) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and target prices for AxoGen and Viveve Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AxoGen 0 0 8 0 3.00
Viveve Medical 0 1 8 0 2.89

AxoGen presently has a consensus target price of $35.57, suggesting a potential downside of 17.75%. Viveve Medical has a consensus target price of $9.43, suggesting a potential upside of 386.01%. Given Viveve Medical’s higher probable upside, analysts clearly believe Viveve Medical is more favorable than AxoGen.

Institutional & Insider Ownership

68.1% of AxoGen shares are owned by institutional investors. Comparatively, 40.6% of Viveve Medical shares are owned by institutional investors. 7.9% of AxoGen shares are owned by company insiders. Comparatively, 35.1% of Viveve Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

AxoGen has a beta of -0.04, indicating that its share price is 104% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of -0.44, indicating that its share price is 144% less volatile than the S&P 500.


This table compares AxoGen and Viveve Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AxoGen -18.83% -61.66% -21.29%
Viveve Medical -269.24% -437.98% -103.63%

Valuation & Earnings

This table compares AxoGen and Viveve Medical’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
AxoGen $60.43 million 24.81 -$10.44 million ($0.31) -139.35
Viveve Medical $15.29 million 3.95 -$36.95 million ($2.11) -0.91

AxoGen has higher revenue and earnings than Viveve Medical. AxoGen is trading at a lower price-to-earnings ratio than Viveve Medical, indicating that it is currently the more affordable of the two stocks.


AxoGen beats Viveve Medical on 10 of the 12 factors compared between the two stocks.

AxoGen Company Profile

AxoGen, Inc. develops and markets surgical solutions for peripheral nerve injuries. The company's surgical solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

Viveve Medical Company Profile

Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

Receive News & Ratings for AxoGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply